| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
75,842 |
67,044 |
$6.68M |
| 99199 |
Unlisted special service, procedure or report |
667,701 |
353,584 |
$4.81M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
72,441 |
62,944 |
$4.36M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
21,245 |
18,578 |
$1.81M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
17,047 |
15,571 |
$1.46M |
| 99050 |
|
49,201 |
43,469 |
$1.20M |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
13,030 |
11,719 |
$1.11M |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
22,604 |
18,919 |
$872K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
8,311 |
7,073 |
$740K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
26,428 |
25,472 |
$517K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
13,301 |
12,918 |
$398K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
20,675 |
18,902 |
$191K |
| D0145 |
Oral evaluation for a patient under three years of age |
5,614 |
5,331 |
$188K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
9,302 |
7,728 |
$185K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
13,877 |
12,388 |
$179K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
12,183 |
5,556 |
$158K |
| 99401 |
|
4,652 |
3,474 |
$138K |
| 99215 |
Prolong outpt/office vis |
831 |
782 |
$88K |
| 87070 |
|
9,038 |
8,042 |
$88K |
| D1206 |
Topical application of fluoride varnish |
5,617 |
5,331 |
$83K |
| 92551 |
|
28,151 |
24,795 |
$55K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,183 |
1,029 |
$44K |
| 90474 |
|
2,173 |
2,128 |
$44K |
| 90837 |
Psychotherapy, 53 minutes with patient |
401 |
201 |
$39K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
594 |
543 |
$36K |
| 96127 |
|
9,007 |
7,697 |
$35K |
| 99460 |
|
473 |
430 |
$34K |
| 90651 |
|
1,141 |
969 |
$28K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
758 |
638 |
$26K |
| 99173 |
|
30,778 |
27,093 |
$23K |
| 83655 |
|
1,291 |
1,191 |
$17K |
| 90686 |
|
12,257 |
11,143 |
$13K |
| 90734 |
|
725 |
668 |
$13K |
| 81025 |
|
1,622 |
1,314 |
$11K |
| 0002A |
|
193 |
148 |
$10K |
| 99462 |
|
291 |
211 |
$9K |
| 94375 |
|
348 |
342 |
$9K |
| 0001A |
|
172 |
133 |
$8K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
860 |
752 |
$7K |
| 90791 |
Psychiatric diagnostic evaluation |
52 |
44 |
$7K |
| 0071A |
|
126 |
87 |
$5K |
| 96160 |
|
1,859 |
1,402 |
$5K |
| 90461 |
|
347 |
289 |
$5K |
| A4627 |
Spacer, bag or reservoir, with or without mask, for use with metered dose inhaler |
76 |
67 |
$4K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
29 |
29 |
$3K |
| 90785 |
|
2,822 |
2,449 |
$3K |
| 87807 |
|
174 |
147 |
$2K |
| 90633 |
|
3,130 |
2,902 |
$2K |
| 0072A |
|
38 |
30 |
$2K |
| 90619 |
|
557 |
470 |
$2K |
| 90834 |
Psychotherapy, 45 minutes with patient |
27 |
12 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
112 |
108 |
$2K |
| 96156 |
|
49 |
44 |
$2K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
112 |
111 |
$1K |
| 99464 |
|
25 |
25 |
$1K |
| 99070 |
|
200 |
178 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
132 |
120 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
435 |
401 |
$1K |
| 81000 |
|
289 |
250 |
$1K |
| 90671 |
|
1,278 |
1,196 |
$665.40 |
| 90715 |
|
181 |
160 |
$488.09 |
| 90670 |
|
7,345 |
6,831 |
$460.77 |
| 94664 |
|
40 |
37 |
$400.68 |
| 85014 |
|
141 |
130 |
$297.63 |
| 96150 |
|
61 |
58 |
$268.17 |
| 90656 |
|
732 |
678 |
$185.67 |
| 90698 |
|
9,668 |
8,933 |
$108.07 |
| 86308 |
|
16 |
13 |
$102.08 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
186 |
132 |
$100.00 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
82 |
68 |
$96.97 |
| 91307 |
|
381 |
273 |
$87.64 |
| 90744 |
|
2,379 |
2,182 |
$76.60 |
| 36416 |
|
2,064 |
1,882 |
$41.08 |
| 90621 |
|
46 |
37 |
$4.25 |
| 94760 |
|
31 |
24 |
$2.17 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
64 |
56 |
$1.30 |
| 1031F |
|
214 |
204 |
$0.00 |
| 90680 |
|
4,287 |
3,992 |
$0.00 |
| 90716 |
|
2,061 |
1,883 |
$0.00 |
| 99000 |
|
5,168 |
4,686 |
$0.00 |
| 90696 |
|
522 |
494 |
$0.00 |
| 3008F |
|
10,247 |
9,621 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
311 |
271 |
$0.00 |
| 2015F |
|
373 |
360 |
$0.00 |
| 2016F |
|
369 |
357 |
$0.00 |
| 2030F |
|
229 |
226 |
$0.00 |
| 2001F |
|
127 |
126 |
$0.00 |
| 4056F |
|
140 |
139 |
$0.00 |
| 90677 |
|
853 |
751 |
$0.00 |
| 4058F |
|
140 |
139 |
$0.00 |
| 1038F |
|
25 |
25 |
$0.00 |
| 4140F |
|
12 |
12 |
$0.00 |
| 90685 |
|
714 |
708 |
$0.00 |
| 90707 |
|
2,175 |
1,988 |
$0.00 |
| 4124F |
|
4,197 |
4,089 |
$0.00 |
| 3210F |
|
541 |
521 |
$0.00 |
| 4120F |
|
243 |
235 |
$0.00 |
| 1039F |
|
78 |
75 |
$0.00 |
| 91300 |
|
406 |
283 |
$0.00 |
| 90713 |
|
12 |
12 |
$0.00 |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
26 |
26 |
$0.00 |
| J7610 |
Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg |
38 |
31 |
$0.00 |